Expression of insulin-like growth factor II in hepatitis B, cirrhosis and hepatocellular carcinoma: its relationship with hepatitis B virus antigen expression
- PMID: 7927218
- DOI: 10.1002/hep.1840200404
Expression of insulin-like growth factor II in hepatitis B, cirrhosis and hepatocellular carcinoma: its relationship with hepatitis B virus antigen expression
Abstract
Expression of insulin-like growth factor II in two human hepatocellular carcinoma cell lines and in hepatitis B, cirrhosis and hepatocellular carcinoma in 419 cases were investigated, and its relationship with the expression of hepatitis B virus X gene was studied by means of immunohistochemical and electron microscopic techniques. The results demonstrated that hepatocellular carcinoma cells (SMMC 7721 and QGY 7703) in culture could express insulin-like growth factor II. Expression seemed to be regulated by cell density, which was suggested as the molecular basis of the contact inhibition of cell proliferation. In tissue sections, cells with high expression of insulin-like growth factor II were observed not only in hepatocellular carcinoma (93%) but also in 95% of the pericancerous liver tissues, 72% of cirrhotic livers, 64% of chronic active hepatitis and 37% of chronic persistent hepatitis. In most cases of hepatocellular carcinoma, insulin-like growth factor II was localized in the cytoplasm of the cancer cells. In the benign liver disorders, four types of cells that highly expressed insulin-like growth factor II were observed: (a) a kind of small liver cell we named the small polygonal liver cell; (b) multinuclear giant hepatocytes; (c) hepatocytes in most of hyperplastic and neoplastic nodules, small hepatocyte nodules and some of regenerative nodules; and (d) some proliferating ductular cells. Even more interestingly, insulin-like growth factor II expression was shown to be closely related to the expression of hepatitis B virus X gene product. We suggest that the activation of insulin-like growth factor II gene and its overexpression may be a crucial step in the processes of hepatitis B virus-associated hepatocarcinogenesis and that the X gene product may activate the insulin-like growth factor II gene through a transactivation mechanism. In addition, we studied the characteristics of small polygonal liver cells, and the roles they may play in the regeneration and carcinogenesis of hepatitis B virus-infected liver are discussed.
Similar articles
-
Differential expression of transforming growth factor alpha and insulin-like growth factor II in chronic active hepatitis B, cirrhosis and hepatocellular carcinoma.J Hepatol. 1995 Mar;22(3):286-94. doi: 10.1016/0168-8278(95)80281-9. J Hepatol. 1995. PMID: 7608479
-
Expression of insulin-like growth factor II in chronic hepatitis B, liver cirrhosis, and hepatocellular carcinoma.Gan To Kagaku Ryoho. 1995 Aug;22 Suppl 3:292-307. Gan To Kagaku Ryoho. 1995. PMID: 7661600
-
Regulation of insulin-like growth factor II gene expression by hepatitis B virus in hepatocellular carcinoma.Hepatology. 1991 Feb;13(2):310-5. Hepatology. 1991. PMID: 1847351
-
Relationship between hepatocyte proliferation and hepatitis delta virus replication in neoplastic and non-neoplastic liver tissues.J Viral Hepat. 1997 Mar;4(2):93-8. doi: 10.1111/j.1365-2893.1997.tb00210.x. J Viral Hepat. 1997. PMID: 9097264 Review.
-
Hepatitis B virus x protein in the pathogenesis of hepatitis B virus-induced hepatocellular carcinoma.J Gastroenterol Hepatol. 2011 Jan;26 Suppl 1:144-52. doi: 10.1111/j.1440-1746.2010.06546.x. J Gastroenterol Hepatol. 2011. PMID: 21199526 Review.
Cited by
-
Liver cell adenoma: a case report with clonal analysis and literature review.World J Gastroenterol. 2006 Apr 7;12(13):2125-9. doi: 10.3748/wjg.v12.i13.2125. World J Gastroenterol. 2006. PMID: 16610069 Free PMC article.
-
Cloning of differentially expressed genes in human hepatocellular carcinoma and nontumor liver.World J Gastroenterol. 2001 Aug;7(4):579-82. doi: 10.3748/wjg.v7.i4.579. World J Gastroenterol. 2001. PMID: 11819835 Free PMC article. No abstract available.
-
Identification of serologic biomarkers for predicting microvascular invasion in hepatocellular carcinoma.Oncotarget. 2016 Mar 29;7(13):16362-71. doi: 10.18632/oncotarget.7649. Oncotarget. 2016. PMID: 26918350 Free PMC article.
-
Advantages of assaying telomerase activity in ascites for diagnosis of digestive tract malignancies.World J Gastroenterol. 2004 Sep 1;10(17):2468-71. doi: 10.3748/wjg.v10.i17.2468. World J Gastroenterol. 2004. PMID: 15300886 Free PMC article. Clinical Trial.
-
A methylated oligonucleotide inhibits IGF2 expression and enhances survival in a model of hepatocellular carcinoma.J Clin Invest. 2003 Jan;111(2):265-73. doi: 10.1172/JCI15109. J Clin Invest. 2003. PMID: 12531883 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical